Outcomes post kidney transplantation amongst First Nations Australians in the Northern Territory.

IF 2.9
Frontiers in nephrology Pub Date : 2025-10-09 eCollection Date: 2025-01-01 DOI:10.3389/fneph.2025.1677030
Farhan Ali Khan, Katherine A Barraclough, Sandawana William Majoni, Sajan Thomas, Wathsala Munasinghe, Asanga Abeyaratne, Robert Carroll
{"title":"Outcomes post kidney transplantation amongst First Nations Australians in the Northern Territory.","authors":"Farhan Ali Khan, Katherine A Barraclough, Sandawana William Majoni, Sajan Thomas, Wathsala Munasinghe, Asanga Abeyaratne, Robert Carroll","doi":"10.3389/fneph.2025.1677030","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>1)To compare graft and patient survival rates following deceased donor kidney transplantation in Northern Territory (NT) First Nations Australians between 2001-2011 and 2012-2021. 2)To compare transplant outcomes between First Nations and non-Indigenous Australians during 2012-2021. 3)To assess the impact of eplet mismatches and predicted indirectly recognizable HLA epitopes II (PIRCHE) scores on transplant outcomes in First Nations Australians.</p><p><strong>Background: </strong>Despite advancements in transplant outcomes across Australia, uncertainty exists regarding improvements in graft and patient survival rates for NT First Nations Australians. No study has evaluated the impact of molecular matching on post-transplant outcomes for NT First Nations Australians.</p><p><strong>Methods: </strong>We performed a retrospective cohort study involving NT First Nations Australians transplanted between 2001-2021. Participants were divided into two groups: 2001-2011 and 2012-2021. For comparison, we also included non-Indigenous recipients transplanted during the 2012-2021 period. We analyzed graft and patient survival using Kaplan-Meier curves and assessed the association of eplets and PIRCHE scores with graft outcomes and <i>de novo</i> donor specific antibody (dnDSA) formation.</p><p><strong>Results: </strong>Five-year graft and patient survival rates were 46% and 66% in the 2001-2011 cohort compared with 69.7% and 83.1% in the 2012-2021 cohort. For non-Indigenous recipients (2012-2021), 5-year graft and patient survival were 90.5% and 97.6%. Higher eplet mismatch loads and PIRCHE scores were not associated with graft survival, patient survival, or time to rejection among First Nations Australians.</p><p><strong>Conclusion: </strong>Post-transplant outcomes for First Nations Australians have improved considerably, but they remain inferior to non-Indigenous Australians.</p>","PeriodicalId":73091,"journal":{"name":"Frontiers in nephrology","volume":"5 ","pages":"1677030"},"PeriodicalIF":2.9000,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12545150/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in nephrology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fneph.2025.1677030","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: 1)To compare graft and patient survival rates following deceased donor kidney transplantation in Northern Territory (NT) First Nations Australians between 2001-2011 and 2012-2021. 2)To compare transplant outcomes between First Nations and non-Indigenous Australians during 2012-2021. 3)To assess the impact of eplet mismatches and predicted indirectly recognizable HLA epitopes II (PIRCHE) scores on transplant outcomes in First Nations Australians.

Background: Despite advancements in transplant outcomes across Australia, uncertainty exists regarding improvements in graft and patient survival rates for NT First Nations Australians. No study has evaluated the impact of molecular matching on post-transplant outcomes for NT First Nations Australians.

Methods: We performed a retrospective cohort study involving NT First Nations Australians transplanted between 2001-2021. Participants were divided into two groups: 2001-2011 and 2012-2021. For comparison, we also included non-Indigenous recipients transplanted during the 2012-2021 period. We analyzed graft and patient survival using Kaplan-Meier curves and assessed the association of eplets and PIRCHE scores with graft outcomes and de novo donor specific antibody (dnDSA) formation.

Results: Five-year graft and patient survival rates were 46% and 66% in the 2001-2011 cohort compared with 69.7% and 83.1% in the 2012-2021 cohort. For non-Indigenous recipients (2012-2021), 5-year graft and patient survival were 90.5% and 97.6%. Higher eplet mismatch loads and PIRCHE scores were not associated with graft survival, patient survival, or time to rejection among First Nations Australians.

Conclusion: Post-transplant outcomes for First Nations Australians have improved considerably, but they remain inferior to non-Indigenous Australians.

Abstract Image

Abstract Image

Abstract Image

在北领地的澳大利亚原住民中,肾移植后的结果。
目的:1)比较2001-2011年和2012-2021年澳大利亚北部地区(NT)原住民死亡供体肾移植后的移植和患者存活率。2)比较2012-2021年第一民族和非土著澳大利亚人的移植结果。3)评估eplet错配和预测间接可识别的HLA表位II (PIRCHE)评分对澳大利亚原住民移植结果的影响。背景:尽管澳大利亚各地的移植结果取得了进展,但NT原住民澳大利亚人在移植和患者存活率方面的改善存在不确定性。没有研究评估分子匹配对澳大利亚NT原住民移植后结果的影响。方法:我们进行了一项回顾性队列研究,涉及2001-2021年间移植的NT原住民澳大利亚人。参与者分为两组:2001-2011年和2012-2021年。为了进行比较,我们还纳入了2012-2021年期间移植的非土著受体。我们使用Kaplan-Meier曲线分析移植物和患者生存,并评估eplets和PIRCHE评分与移植物结局和新生供体特异性抗体(dnDSA)形成的关系。结果:2001-2011年队列的5年移植和患者生存率分别为46%和66%,而2012-2021年队列的5年移植和患者生存率分别为69.7%和83.1%。对于非本土受体(2012-2021),5年移植和患者生存率分别为90.5%和97.6%。在澳大利亚原住民中,较高的eplet错配负荷和PIRCHE评分与移植物存活、患者存活或排异反应时间无关。结论:土著澳大利亚人移植后的预后有了很大的改善,但仍然不如非土著澳大利亚人。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书